International Cancer Screening Network Conference 2025 (ICSN)

Abstracts

Call for Abstracts, Guidelines

Call for abstracts is open by October 7, 2024
Deadline for abstract submission: January 2, 2025, at 14:00 PM CET.

We are now accepting abstract submissions on relevant topics for ICSN 2025 in Aarhus, Denmark. The overarching theme of the conference is ”Shaping the Future of Cancer Screening” with the following subthemes:

Abstract Themes

Communication Strategies and Outreach
This theme invites abstracts that present new strategies for improving cancer screening outcomes in the population, including participation in cancer screening and compliance to any follow-up procedure. Submissions may also focus on communication tactics aimed at healthcare providers, the general population, or specific target groups.

Emerging Cancer Screening Programmes
Abstracts may focus on new or evolving screening programs for cancers like lung, anal, skin, oral, and prostate. Submissions may also explore multicancer early detection tests (MCED) or initiatives aimed at high-risk populations.

Equity in Cancer Screening
Abstracts should explore strategies to address disparities in cancer screening, focusing on vulnerable and disadvantaged populations. Submissions may highlight descriptive research or interventions aimed at improving access and participation. Emphasis on socioeconomic, geographic, and demographic factors is encouraged.

Informed Choice in Screening: Understanding and Communicating Benefits and Harms
This theme invites abstracts that examine methods for communicating the benefits and harms of cancer screening. Submissions should address how to inform citizens in a balanced way, while helping them make informed decisions regarding screening participation.

Methodologies in Cancer Screening Evaluation
Abstracts under this theme should focus on epidemiological methods or any other method used to evaluate the effectiveness and efficiency of screening programs. Topics may include the measurement of screening benefits and harms, modelling analysis, cost-effectiveness analysis, and strategies to improve program evaluation.

New Technologies, Tests, Procedures, and Evaluation in Cancer Screening Programmes
This theme seeks abstracts that discuss advancements in cancer screening technology, such as but not limited to AI-driven diagnostics, novel tests, and procedures. This include the screening test or any screening derived diagnostic procedure. Submissions may include evaluations of these innovations in current or future screening programs.

Quality Assurance in Cancer Screening
Abstracts should address methods for ensuring high-quality cancer screening, including laboratory protocols, audits, and the use of key performance indicators (KPIs). Submissions may explore strategies to monitor screening processes, uptake, and outcomes for continuous improvement.

Risk-Based/Personalized Screening
This theme invites abstracts on flexible screening programs that consider individual risk factors. Submissions may include genetic profiling, biomarker panels, or other methods to optimize screening based on personal risk. Research that challenges the "one-size-fits-all" approach is highly relevant.

Screening Priorities from a Global Perspective
This theme seeks abstracts addressing cancer screening challenges and solutions in low- and middle-income countries (LMICs). Submissions should focus on global health disparities, strategies for improving screening access, and tailored programs for underserved regions, particularly in the Global South.

Stakeholder Engagement
Abstracts should explore strategies for involving stakeholders—patients, healthcare professionals, and policymakers—in cancer screening program design and implementation. Topics on involving patients or citizens in research is also covered here. Submissions may highlight successful models of public and professional engagement that enhance program delivery and outcomes.

If your research aligns with one of the selected themes, we encourage you to submit your abstract according to the following guidelines.

Guidelines

Please find Guidelines here

The submitter of the abstract is the corresponding author. If the corresponding author should not appear on the authors list, this must be communicated to Kongreskompagniet by email: icsnabstract@kongreskompagniet.dk

1. Abstract

Abstracts must be written in English.
The font and text size will be predefined in the portal and will automatically be adjusted.
The abstract text must be written as plain text (i.e., no use of highlighting).
A title that indicates the nature of the investigation.
The title should not exceed 50 words and should be written in sentence case. Please refrain from adding a full stop (.) at the end of the title.
Avoid abbreviations in the abstract title. However, abbreviations may be used in the text if they are defined the first time they appear.
The authors’ names (full first names, family names) and places of work (Institution, City, Country) must be included.
The presenting author must be indicated (there should be only one presenting author). The presenting author must be registered for the conference. Registration must be completed no later than: March 15, 2025.
The abstract text should be stating:

1.   The specific objective of the study (Introduction)

2.   The methods used (Materials and Methods)

3.   The results obtained (Results)

4.   The conclusions reached (Conclusion)

All abstract texts will be provided to reviewers and published in the ICSN app exactly as submitted. Kongreskompagniet will not perform any proofreading of the abstract text.
The abstract text should not exceed 250 words, excluding author details and headings.
It will be possible to upload one figure as a PNG file. The caption can be up to 50 words and shall be added in a separate text field.
References are allowed and must be submitted in a separate text field.
Acknowledgements are allowed and must be submitted in a separate text field.

Submission

Abstracts may only be submitted electronically through the ICSN website. Abstracts sent by mail, email or fax will not be accepted.
Abstracts must be submitted by: January 2, 2025, 14:00 PM CET.
Using the drop-down menu, you can select a category (oral or poster), and in the sub-menu, you should choose the theme related to your abstract. However, the Scientific Committee reserves the right to determine the final presentation category.
Abstracts can be saved in draft status and updated before the submission deadline. Changes to the abstract text cannot be implemented after expiry of the submission deadline. Withdrawal of the abstract can only be done by emailing icsnabstract@kongreskompagniet.dk
The submission system will generate a confirmation by email when upload of the abstract has been completed, of which a paper number appears. Please refer to the paper number in any correspondence related to the abstract submission.